- Coldcard hackers transfer 64 BTC and 200 ETH to cryptocurrency mixers
- Saudi Arabia lowers September official selling prices for Asia to more than five-year lows, regional crude oil pricing influenced by Hormuz negotiations
- Unity surged more than 16% in pre-market US trading; the company's adjusted earnings per share for the second quarter were $0.28, and revenue reached $546.5 million, both exceeding market expectations.
- VIAVI SOLUTIONS INC. <VIAV.O>: STIFEL RAISES TARGET PRICE TO $65 FROM $60
- FLUTTER ENTERTAINMENT PLC <FLUT.N>: STIFEL CUTS TARGET PRICE TO $133 FROM $161
- ZIMMER BIOMET HOLDINGS, INC. <ZBH.N>: STIFEL RAISES TARGET PRICE TO $110 FROM $105
- EXELIXIS INC <EXEL.O>: STIFEL RAISES TARGET PRICE TO $51 FROM $47
- US Foods Q2 FY26 adjusted EBITDA climbs 10.2% to $604 million; net sales rise 4.5% to $10.53 billion
- Lincoln International Q2 FY26 GAAP net income turns to profit at $455,000; revenue rises 51% to $225.7 million
- Paramount Resources issues corporate presentation outlining plan to lift output above 100,000 boe/d by end-2027
- SUNCOR ENERGY INC (CANADA) <SU.TO>: RAYMOND JAMES RAISES TARGET PRICE TO C$109 FROM C$103
- Foghorn Therapeutics Q2 FY26 net loss narrows to $7.2 million; collaboration revenue rises to $16.1 million
- Monte Rosa activates Phase 2 MODeFIRe-1 trial of MRT-2359 plus apalutamide in metastatic prostate cancer
- TIC Solutions Q2 FY26 net loss widens to $13.34 million; revenue rises 86% to $584.35 million
- Howmet Q2 FY26 GAAP EPS rises 33% to $1.33; revenue climbs 24% to $2.55 billion
- Qnity CEO Jon Kemp to speak at Deutsche Bank Technology Conference fireside chat
- Marten Transport FY26 Q2 net income drops 25.7% to $5.3 million; revenue falls 2.8% to $223.54 million
- LEGALZOOM.COM, INC. <LZ.O>: WILLIAM BLAIR CUTS TO MARKET PERFORM RATING
- PROPEL HOLDINGS INC : RAYMOND JAMES RAISES TO STRONG BUY FROM OUTPERFORM; RAISES TARGET PRICE TO C$38 FROM C$31
- FrontView REIT Q2 FY26 net income swings to profit of $1.52 million; revenue rises 2.57% to $18.01 million
- US Stock Movement | Palo Alto Networks (PANW.US) dropped as much as 4% pre-market after its products sold in China faced cybersecurity review
- PUMP price tests channel top after 35% weekly gain
- US Stock Movement | Palo Alto Networks (PANW.US) fell as much as 4% in pre-market trading as its products in China face cybersecurity review
- Warner Bros. Discovery (WBD.US): The World Cup had a negative impact on the audience share and advertising spending in international markets in June and July.
- Marriott Vacations Q2 FY26 net income rises 11% to $77 million; contract sales increase 22% to $545 million
- Tripadvisor Q2 FY26 net income drops 38% to USD 22.8 million; revenue falls 7% to USD 441.9 million
- Ironwood Q2 FY26 GAAP net income rises 117% to $51.29 million; revenue increases 33% to $113.04 million
- Peloton FY26 net income turns to profit at $63.2 million; revenue falls 3.04% to $2.45 billion
- Smith Douglas Homes Q2 FY26 EPS drops to $0.03; revenue rises 22% to $273 million
- Tecnoglass Q2 FY26 net income drops to $24.6 million; revenue rises 15.6% to $295.3 million
- Appian 2Q Loss/Shr 16c >APPN
- Tarsus Pharmaceuticals 2Q Rev $173.9M >TARS
- Zoetis Sees 2026 Adj EPS $6.15-Adj EPS $6.25 >ZTS
- Viridian Therapeutics 1Q Loss/Shr $69.72 >VRDN
- Zoetis Sees 2026 Rev $9.12B-$9.32B >ZTS
- Viridian Therapeutics 1Q Rev $284,000 >VRDN
- Tarsus Pharmaceuticals: Deal Also Includes Milestones Up to $350M Upon Potential Regulatory Approval and First Comml Sale >TARS
- Axcelis Q2 FY26 GAAP diluted EPS falls 23.47% to 0.75; revenue rises 10.61% to 215.2 million
- Papa John’s FY26 Q2 diluted EPS drops 14.29% to $0.24; revenue falls 8.8% to $482.4 million
- Unusual Machines Q2 FY26 operating loss widens to $7.8 million; revenue rises 687% YoY to $16.7 million
- Ongwe Minerals plans 5,000-meter diamond drill program at Nguni gold prospect in Namibia
- Ocugen Q2 FY26 net loss widens to $24.88 million; revenue rises to $1.49 million
- Insmed Q2 FY26 net loss narrows to $13.2 million; revenue rises 296% to $425.5 million
- Arbe Robotics names Assaf Pereg CFO, replacing Karine Pinto-Flomenboim
- Open Text 4Q Adj EPS $1.23 >OTEX
- Tarsus Pharmaceuticals: Deal Incluses Upfront Consideration of About $450M, Consisting of $270M in Cash and $180M in Tarsus Common Stk >TARS
- Aya Gold & Silver acquires Morocco exploration portfolio for MAD 10 million
- Appian Q2 FY26 GAAP net loss widens to $11.82 million; revenue rises 19% to $203.26 million
- Resolute Holdings FY26 Q2 net loss per share widens to $(1.53); non-GAAP fee-related EPS climbs to $0.69
- Artemis Gold Q2 2026 profit rises as Blackwater mine posts higher grades, recoveries and throughput, company says
- BlackSky Q2 FY26 net loss narrows to $20.8 million; revenue rises 50% YoY to $33.3 million
- Ono Pharma partners with Mediar Therapeutics on antibody drugs for fibro-inflammatory diseases
- Datadog Q2 FY26 net income swings to USD 44.56 million; revenue rises 36% year-over-year to USD 1.12 billion
- Sionna net loss widens 65.43% to $29.89 million in Q2 FY26
- Lifetime Brands Q2 FY26 swings to GAAP net income of $19.61 million; net sales rise 7.4% to $141.57 million
- Nexstar FY26 Q2 net income rises 24.2% to $113 million; net revenue climbs 62.2% to $1.66 billion
- BRIEF-Driven Brands Holdings Inc Q2 Revenue USD 507.4 Million
- Lantheus Q2 FY26 GAAP EPS slips 0.9% to $1.11; revenue rises 2.7% to $388.2 million
- SITIME CORPORATION <SITM.O>: NEEDHAM RAISES TARGET PRICE TO $900 FROM $850
- ConocoPhillips names Andy O’Brien CEO, succeeding Ryan Lance
- Avalo Q2 FY26 net loss widens to $36.4 million; R&D expense rises 66.1% to $23.4 million
- Vistance Networks Q2 FY26 GAAP income from continuing operations rises to $26.1 million; net sales slip 1.4% to $319.6 million
- Versant Media Group Raises FY26 View To Rev $6.2B-$6.45B >VSNT
- CareCloud Backs 2026 EPS 20c-EPS 23c >CCLD
- CareCloud Backs 2026 Rev $128M-$132M >CCLD
- CareCloud 2Q Adjusted EBITDA $5.9M >CCLD
- Intellia Therapeutics 2Q Rev $7.66M >NTLA
- Korro Bio Q2 FY26 net loss narrows to USD 18.92 million; revenue posts no collaboration revenue
- Aeva management participates in Canaccord Genuity Annual Growth Conference
- Immunocore Q2 FY26 net loss narrows to $0.8 million; revenue rises 18% to $115.9 million
- BKV Q2 FY26 net income falls 29.68% to $75.8 million; adjusted EBITDAX climbs 47.15% to $142 million
- Tarsus Q2 FY26 net loss narrows 8.77% to $18.55 million; net product sales rise more than 69% to $173.91 million
- Viridian net loss widens to $127.12 million in Q2 FY26; SG&A expenses climb to $54.98 million
- Paramount Resources Q2 FY26 net income rises 1,526% to $68.3 million
- ConocoPhillips: Andy O'Brien Named Pres and CEO
- Monte Rosa Therapeutics 2Q Research and Development $48.0M >GLUE
- Climb Bio Q2 FY26 net loss widens 55.73% to $13.5 million
- Cullinan Q2 FY26 net loss narrows 23.36% to $53.7 million
- Rogers Sugar FY26 Q3 net income drops 16.42% to $12.06 million; revenue falls 8.35% to $293.7 million
- Versant net income drops 30.1% to $211 million in FY26 Q2; revenue falls 3.8% to $1.64 billion
- Zoetis names Jay Saccaro CFO, COO effective Aug. 17, 2026
- Opus Genetics Q2 FY26 net loss widens to $8.1 million; revenue drops to $755,000
- Amylyx Q2 FY26 net loss widens to $43.4 million; SG&A expenses climb to $21.9 million
- Monte Rosa Therapeutics 2Q Rev $8.97M >GLUE
- Ligand Pharmaceuticals Adjusts FY View To Adj EPS $9.00-Adj EPS $9.50 >LGND
- Versant Media Group 2Q EPS $1.49 >VSNT
- Vistance Networks 2Q Sales $319.6M >VISN
- Mastech Digital Q2 FY26 GAAP net income turns to loss of $100,000; revenue drops 15.6% to $41.45 million year over year
- Iovance Q2 operating loss narrows to $51.91 million; revenue rises 66% year over year to $99.31 million
- CPI Card Group Q2 FY26 net income swings to profit of $2 million; revenue rises 15% to $149 million
- Evergy Q2 FY26 GAAP EPS rises to $0.91; adjusted EPS climbs to $0.88
- Aclaris Q2 FY26 net loss widens to $21.5 million; revenue slips to $1.6 million
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- Roivant Sciences 1Q Loss/Shr 26c >ROIV
- Roivant Sciences 1Q Rev $1.44M >ROIV
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Korro Bio 2Q Loss/Shr $1.07 >KRRO
- Korro Bio 2Q Loss $18.9M >KRRO
